InsiderTrades

Form 4 for MRNA Moderna

Accepted 2026-06-03 16:19:34 ET · period of report 2026-06-01 · accession 0001682852-26-000113 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-06-03 16:19 2026-06-01 MRNA Klinger Shannon Thyme CLO M - OptEx — +2,165 68.5K +3% —
D 2026-06-03 16:19 2026-06-01 MRNA Klinger Shannon Thyme CLO F - Tax $47.19 -1,047 67.5K -2% -$49.4K
D 2026-06-03 16:19 2026-06-01 MRNA Klinger Shannon Thyme CLO M - OptEx $0.00 -2,165 23.8K -8% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-06-01 M A 2,165 — 68,515 D — — (F1) Restricted stock units convert into common stock on a one-for-one basis. (F1) Restricted stock units convert into common stock on a one-for-one basis.
2 Common Common Stock 2026-06-01 F D 1,047 $47.19 67,468 D — — (F2) Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
3 Derivative Restricted Stock Units 2026-06-01 M D 2,165 $0.00 23,827 D — · — to — 2,165 Common Stock (F1) Restricted stock units convert into common stock on a one-for-one basis. (F1) Restricted stock units convert into common stock on a one-for-one basis. (F3) 25% of the shares subject to this restricted stock unit award vested on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter. (F3) 25% of the shares subject to this restricted stock unit award vested on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter.